Cargando…
A New Classification of Prodrugs: Regulatory Perspectives
Many therapeutic agents are manufactured and administered in prodrug forms. In this paper, a new classification system for prodrugs is proposed to provide useful information about where in the body a prodrug is converted to the active drug. In this system, prodrugs are classified into Type I or Type...
Autor principal: | Wu, Kuei-Meng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978533/ https://www.ncbi.nlm.nih.gov/pubmed/27713225 http://dx.doi.org/10.3390/ph2030077 |
Ejemplares similares
-
Classification and regulatory perspectives of dietary fiber
por: Dai, Fan-Jhen, et al.
Publicado: (2016) -
New prodrugs of Adefovir and Cidofovir
por: Tichý, Tomáš, et al.
Publicado: (2011) -
Tetrazine-mediated bioorthogonal prodrug–prodrug activation
por: Neumann, Kevin, et al.
Publicado: (2018) -
Prodrugs and prodrug-activated systems in gene therapy
por: Sheikh, Semira, et al.
Publicado: (2021) -
Prodrug Strategies for Paclitaxel
por: Meng, Ziyuan, et al.
Publicado: (2016)